Healthcare Industry News:  otitis media 

Biopharmaceuticals

 News Release - October 15, 2008

Arbor Pharmaceuticals Launches NEOTIC(tm) – A New Prescription Treatment for the Painful Symptoms of Common Middle Ear Infections

Raleigh, NC -–(HSMN NewsFeed)--Arbor Pharmaceuticals announced today that the company’s second prescription product, NEOTIC(tm), has been launched in the U.S. and is now available for the treatment of pain and inflammation associated with middle ear infections (also called Acute otitis media, or AOM). Acute otitis media represents the second most common infection among children in the US and the number one reason antibiotics are prescribed by U.S. pediatricians. AOM accounts for almost 25 million physician office visits in the U.S. each year resulting in over 20 million antibiotic prescriptions.

NEOTIC(tm) is a novel, patented non-antibiotic otic (ear) prescription treatment that combines a unique combination of active ingredients with a convenient dual-unit package for children. NEOTIC(tm) is indicated to relieve pain and reduce inflammation associated with acute otitis media and as an adjunct to oral antibiotic treatment for acute otitis media.

“The launch of NEOTIC(tm) represents another important milestone for Arbor as it demonstrates the Company’s continuing commitment to provide novel therapeutic options for significant pediatric conditions. NEOTIC(tm) is a unique new product for pediatricians and offers significant value to healthcare professionals and the millions of children affected with AOM” says Jarrett Disbrow, President & Chief Executive Officer of Arbor Pharmaceuticals, Inc.

Arbor Pharmaceuticals has partnered with an established specialty pharmaceutical company to promote NEOTIC(tm) to physicians across the U.S. NEOTIC(tm) is available by prescription only through retail pharmacies throughout the U.S.

For more information about NEOTIC(tm), please visit www.arborpharma.com.

Serious side effects are unlikely with NEOTIC(tm). Patients may experience burning, stinging, redness and/or new pain in or around the ears.

Corporate Contact for Media Inquiries:

Jarrett Disbrow
President and Chief Executive Officer
Arbor Pharmaceuticals, Inc.
(919) 792-1701

About Arbor Pharmaceuticals

Arbor Pharmaceuticals is a Raleigh, North Carolina based specialty pharmaceutical company focused on the licensing, development, and commercialization of products for pediatricians. Founded in 2006, Arbor actively identifies and licenses unique, patent-protected therapies proven to effectively treat common pediatric illnesses. Arbor Pharmaceuticals collaborates with pharmaceutical development companies and established promotional partners in the pharmaceutical industry to develop and market their products in order to serve the needs of pediatricians throughout the US.

To learn more about Arbor Pharmaceuticals, visit www.arborpharma.com or send email inquiries to info@arborpharma.com.


Source: Arbor Pharmaceuticals

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.